Send feedback

MYO7A p.Pro694Leu

c.2081C>T · rs200057810 · VCV623785

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
AlphaMissense
likely pathogenic
0.5789 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.5789likely pathogenic
REVEL0.532indeterminate
SaProtLLR -11.53damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 1.4, phastCons 1
Regional constrainto/e 0.95unconstrained · MANE · 84 kb · p 0.0065 · regional, not allelic
Overall
CADD25.9PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0164% Middle Eastern · 1/6,084 alleles
Filtering AF 0.00921% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00774%
Overall 0.00868% 140/1,613,484 alleles · ultra-rare exomes 125/1,461,308 · genomes 15/152,176 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0203% 4,933
Middle Easterngrpmax 0.0164% 6,084
African / African-American 0.016% 6,243
European (non-Finnish) 0.00975% 10,259
Remaining individualsnot grpmax-eligible 0.0064% 15,615
East Asian 0.00446% 22,443

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7A
Protein
p.Pro694Leu
Coding
c.2081C>T
MANE Select
NM_000260
dbSNP
rs200057810
Type
single nucleotide variant
Location
chr11:77174901 (GRCh38)
Gene constraint
LOEUF 0.995 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 77.73 · 1 PDB
Residue 694
the myosin motor domain
Full MYO7A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7a-p-pro694leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown